BSE filing, NSE: FORTISMLR. Summary written from the filing by ALFA Finder's alert engine.
Fortis Malar Hospitals Ltd: key numbers
- Share price
- ₹40.57
- Market cap
- ₹76.04 Cr
- Revenue (annual)
- ₹0.05 Cr
- Net profit (annual)
- ₹4.14 Cr
- P/E (TTM)
- 555.8×Sector 52.0×
- Promoter holding
- 62.71%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Fortis Malar Hospitals Ltd
All →Fortis Malar Hospitals Board Meeting Date
Fortis Malar Hospitals Ltd intimated a board meeting on 3 November 2026 to consider unaudited standalone and consolidated results for the quarter and half year ended 30 September 2026. The trading window remains closed until 5 November 2026.
Fortis Malar Hospitals Management Change
Dr. Ritu Garg resigned as Non-Executive Non-Independent Director of Fortis Malar Hospitals on October 27, 2026. The board appointed Dr. S Narayani in her place, effective the same date.
Fortis Malar Hospitals Other Announcement
The company submitted its quarterly shareholding pattern as required under SEBI Regulation 31. This routine filing provides no material business event or transaction.
Fortis Malar Hospitals Q1 FY27 Results: Net Profit ₹0.2 Cr, Down 95.2% YoY
Fortis Malar Hospitals Ltd reported net profit of ₹0.2 Cr (-95.2% YoY) for Q1 FY27.
- Key figure
- Net profit ₹0.2 Cr · -95.2% YoY
Fortis Malar Hospitals Annual General Meeting
Fortis Malar Hospitals Limited successfully concluded its 35th Annual General Meeting on July 29, 2026. Shareholders considered and adopted the audited financial statements and other business items.
Fortis Malar Hospitals Board Meeting Date
Fortis Malar Hospitals Limited will hold a board meeting on August 04, 2026, to approve its unaudited financial results for the quarter ended June 30, 2026.
Other other announcement announcements
All →Mahindra & Mahindra Financial Services Other Announcement
Mahindra & Mahindra Financial filed its ALM statement as of September 30, 2026, submitted to RBI. It is a periodic regulatory return with no new transaction.
ACME Solar Holdings Other Announcement
ACME Solar filed the CARE Ratings monitoring agency report on its Rs.2,800 crore QIP for the quarter ended 30 September 2026. The report shows no deviation from the offer objects.
eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.